1. Home
  2. RYI vs VIR Comparison

RYI vs VIR Comparison

Compare RYI & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ryerson Holding Corporation

RYI

Ryerson Holding Corporation

HOLD

Current Price

$28.77

Market Cap

843.2M

Sector

Industrials

ML Signal

HOLD

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$6.23

Market Cap

825.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RYI
VIR
Founded
1842
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
843.2M
825.0M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
RYI
VIR
Price
$28.77
$6.23
Analyst Decision
Hold
Strong Buy
Analyst Count
1
8
Target Price
$25.00
$28.63
AVG Volume (30 Days)
304.7K
1.9M
Earning Date
02-19-2026
02-25-2026
Dividend Yield
2.52%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,473,900,000.00
$16,860,000.00
Revenue This Year
$0.38
N/A
Revenue Next Year
$4.72
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$19.02
$4.16
52 Week High
$29.89
$11.39

Technical Indicators

Market Signals
Indicator
RYI
VIR
Relative Strength Index (RSI) 68.04 51.69
Support Level $25.80 $5.69
Resistance Level $29.89 $6.90
Average True Range (ATR) 0.88 0.36
MACD 0.19 0.04
Stochastic Oscillator 79.28 48.52

Price Performance

Historical Comparison
RYI
VIR

About RYI Ryerson Holding Corporation

Ryerson Holding Corp provides a metals service center, and value-added processor and is a distributor of industrial metals with operations in the United States, Canada, and Mexico. In addition to its North American operations, it conducts processing and distribution operations in China. Its customers range from local, independently owned fabricators and machine shops to large, international original equipment manufacturers. It carries a full line of products in stainless steel, aluminum, carbon steel, and alloy steels and a limited line of nickel and red metals in various shapes and forms. The company generates substantially all of its revenue from sales of metal products. Geographically, the majority revenue is generated from the United States.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

Share on Social Networks: